Form 4: STRYKER RONDA E sold SYK
STRYKER RONDA E (Director at STRYKER CORP) reported an open-market sale of 350,000 shares of SYK at an average $336.50, roughly $117,776,128, in a Form 4 filed 2026-08-20.
Past performance does not predict future results. Informational only, not investment advice.
STRYKER RONDA E (Director at STRYKER CORP) reported an open-market sale of 350,000 shares of SYK at an average $336.50, roughly $117,776,128, in a Form 4 filed 2026-08-20.
King Debra (See Remarks at STRYKER CORP) reported an open-market sale of 826 shares of SYK at an average $336.30, roughly $277,787, in a Form 4 filed 2026-08-18.
Stryker is a highest-quality medical device business positioned to benefit from aging populations and robotic surgery adoption, with pricing power, sticky hospital relationships, and consistent acquisition-driven earnings growth.
Surgical robotics market leader with an unbroken 32-year dividend streak, trading below its historical average post-cyberattack. High net debt of $12.3bn is a counterargument.
End of results.